Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

NCT03011450 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

471

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hypertriglyceridemia

Interventions

DRUG: K-877
DRUG: Fenofibrate
DRUG: Placebo (for K-877)

Sponsor

Kowa Research Institute, Inc.